On behalf of the American Statistical Association (Boston, Connecticut, Florida, New Jersey, Princeton/Trenton, and Washington chapters), Boehringer Ingelheim Pharmaceuticals, Inc. (Biostatistics and Data Sciences Department), and the New England Statistical Society (NESS), we cordially invite you to the following webinar:
Topic: A 2-in-1 Adaptive Design to Seamlessly Expand a Selected Dose from a Phase 2 Trial to a Phase 3 Trial for Oncology Drug Development
Speaker: Dr. Eric Zhang, Associated Director, Biostatistics, BeiGene USA, Inc.
Abstract: Please see the attached file
Date: Thursday, November 10, 2022
Time: 9:00-10:00 am EST (New York), including 10-minute Q&A
We are co-sponsoring a series of webinars on innovative statistical methodologies and other related topics. The webinar series is open to the ASA community and general external audiences.
Please feel free to forward the meeting planner to other colleagues. For any questions or help regarding joining the meeting, please send an email to the following: MEDecc.US@boehringer-ingelheim.com with the subject line “I want to attend webinar no.31 on November 10th, please send me the link”.